Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
Enovis (NYSE: ENOV), a medical technology growth company, has announced a time change for its Second Quarter 2024 results conference call. The call will now take place on August 7, 2024, at 8:00 a.m. Eastern Time, earlier than previously scheduled. The date and other details remain unchanged. Investors can access the live webcast through the Enovis website. For call participation, U.S. callers should dial (833) 685-0901, while international callers should use (412) 317-5715. A presentation related to the call will be available on ir.enovis.com, and a replay link will be provided on the website later that day.
Enovis (NYSE: ENOV), un'azienda di tecnologia medica in crescita, ha annunciato un cambio di orario per la sua conferenza sui risultati del secondo trimestre 2024. La chiamata si terrà ora il 7 agosto 2024, alle 8:00 ora orientale, con un anticipo rispetto a quanto precedentemente programmato. La data e altri dettagli rimangono invariati. Gli investitori possono accedere alla diretta web tramite il sito di Enovis. Per partecipare alla chiamata, gli utenti negli Stati Uniti devono comporre il numero (833) 685-0901, mentre gli utenti internazionali devono utilizzare il numero (412) 317-5715. Una presentazione relativa alla chiamata sarà disponibile su ir.enovis.com, e un link per la registrazione sarà fornito sul sito web più tardi nella giornata.
Enovis (NYSE: ENOV), una empresa de tecnología médica en crecimiento, ha anunciado un cambio de horario para su conferencia sobre los resultados del segundo trimestre de 2024. La llamada se realizará ahora el 7 de agosto de 2024, a las 8:00 a.m. hora del Este, más temprano de lo que se había programado anteriormente. La fecha y otros detalles permanecen sin cambios. Los inversores pueden acceder a la transmisión en vivo a través del sitio web de Enovis. Para participar en la llamada, los llamantes de EE.UU. deben marcar (833) 685-0901, mientras que los llamantes internacionales deben usar (412) 317-5715. Se dispondrá de una presentación relacionada con la llamada en ir.enovis.com, y se proporcionará un enlace de reproducción en el sitio web más tarde ese mismo día.
Enovis (NYSE: ENOV)는 성장 중인 의료 기술 회사로, 2024년 2분기 실적 발표 전화 회의의 시간 변경을 발표했습니다. 회의는 이제 2024년 8월 7일, 동부 표준시 오전 8시에 진행되며, 이전에 예정된 시간보다 빨라졌습니다. 날짜와 다른 세부 사항은 변경되지 않았습니다. 투자자들은 Enovis 웹사이트를 통해 생중계를 접속할 수 있습니다. 전화 회의에 참여하려면 미국 내 발신자는 (833) 685-0901로 전화해야 하고, 국제 발신자는 (412) 317-5715를 사용해야 합니다. 회의와 관련된 발표 자료는 ir.enovis.com에서 제공될 예정이며, 이날 중으로 웹사이트에 재생 링크가 게시될 것입니다.
Enovis (NYSE: ENOV), une entreprise de technologie médicale en pleine croissance, a annoncé un changement d'horaire pour sa conférence sur les résultats du deuxième trimestre 2024. L'appel aura désormais lieu le 7 août 2024 à 8h00 heure de l'Est, plus tôt que prévu initialement. La date et d'autres détails restent inchangés. Les investisseurs peuvent accéder au webcast en direct via le site web d'Enovis. Pour participer à l'appel, les appelants américains doivent composer le (833) 685-0901, tandis que les appelants internationaux doivent utiliser le (412) 317-5715. Une présentation liée à l'appel sera disponible sur ir.enovis.com, et un lien de rediffusion sera fourni sur le site plus tard dans la journée.
Enovis (NYSE: ENOV), ein wachsendes Unternehmen im Bereich Medizintechnologie, hat eine Änderung des Zeitplans für seine Konferenz zu den Ergebnissen des zweiten Quartals 2024 bekannt gegeben. Der Anruf findet nun am 7. August 2024 um 8:00 Uhr Eastern Time statt, früher als zuvor geplant. Das Datum und andere Details bleiben unverändert. Investoren können über die Enovis-Website auf den Live-Webcast zugreifen. Für die Teilnahme an dem Anruf sollten US-Anrufer die Nummer (833) 685-0901 wählen, während internationale Anrufer (412) 317-5715 nutzen sollten. Eine Präsentation zu dem Anruf wird auf ir.enovis.com verfügbar sein, und ein Wiederholungslink wird später am Tag auf der Website bereitgestellt.
- None.
- None.
Wilmington, DE, July 25, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced a change in the scheduling of its upcoming earnings results conference call. The call will still take place on August 7, 2024, but will now be held at 8:00 a.m. Eastern Time, instead of the previously announced time. There is no change to the date, the dial-in or webcasting information. A presentation related to the call will be available on ir.enovis.com.
Conference call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.
ABOUT ENOVIS
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Availability of Information on the Enovis Website
Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.
Contact:
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
+1-917-734-7450
investorrelations@enovis.com
FAQ
When is Enovis (ENOV) releasing its Q2 2024 earnings results?
What is the new time for Enovis (ENOV) Q2 2024 earnings call?
How can investors access Enovis (ENOV) Q2 2024 earnings call?
Will there be a replay available for Enovis (ENOV) Q2 2024 earnings call?
